CLINICAL CANCER RESEARCH最新收录文章列表-丁香通

简称Clin Cancer Res

大类医学

小类肿瘤学

ISSN1078-0432

EISSN1557-3265

最新文献

Longitudinal ctDNA Monitoring for Postsurgical Disease Surveillance in Patients with Stage I to IIIB Melanoma

PMID: 416324492026-04-15

Epigenetic Instability-Based Metrics in Cell-Free DNA for Early Cancer Detection

PMID: 415919792026-04-15

Camonsertib, an ATRi, in Combination with Low-Dose Gemcitabine in Solid Tumors with DNA Damage Response Aberrations: Preclinical and Phase Ib Results

PMID: 415633862026-04-15

LRRC15-CAR T Cells for the Treatment of Osteosarcoma

PMID: 416271732026-04-15

ctDNA Dynamics and Recurrence Patterns after Organ-Sparing Trimodality Therapy for Bladder Cancer

PMID: 415871102026-04-15

Decoding B-cell Signatures of Complete Pathologic Response to Perioperative Chemoimmunotherapy in Non-Small Cell Lung Cancer

PMID: 418058952026-04-15

Trop-2.2-Directed Radioimmunotherapy with 177Lu, 225Ac, and 212Pb in a Pancreatic Cancer Model

PMID: 415919782026-04-15

Payload Diversification Overcomes Resistance and Guides Sequential Antibody-Drug Conjugate Therapy in Breast Cancer

PMID: 415919912026-04-15

Neoadjuvant Nivolumab with or without Ipilimumab for Cisplatin-Ineligible Patients with Muscle-Invasive Bladder Cancer

PMID: 416271712026-04-15

Combination Therapy with Copanlisib and Niraparib in Patients with Recurrent Endometrial and Ovarian Cancer (COPANIRA): Efficacy, Toxicity, and Translational Insights

PMID: 415289702026-04-01

Clinicogenomic and Histopathologic Analyses of Supermassive Intrahepatic Cholangiocarcinoma and the Role of Ablative Radiotherapy

PMID: 419233412026-04

Use of ctDNA in Older Women with ER+ Breast Cancer to Facilitate Surgical De-escalation: A Prospective, Hybrid-Decentralized Trial with Correlative Studies

PMID: 418544112026-03-19

Integrated single-cell and spatial analysis reveals context-dependent myeloid-T cell interactions in response to immune checkpoint blockade in head and neck cancer

PMID: 418377442026-03-16

Pre-existing TCR clones drive major pathological responses in HNSCC patients treated with dual immune checkpoint inhibitors

PMID: 417850142026-03-05

Association of Circulating T Cell and Tumor Microenvironment Profiles with Immune Checkpoint Blockade Outcome in Sarcoma

PMID: 416778572026-02-12

A phase II study of docetaxel and pembrolizumab plus Interleukin-12 gene therapy in non-metastatic, anthracycline-refractory triple negative breast cancer (INTEGRAL)

PMID: 416612182026-02-09

FET-Rearranged Myoepithelial Tumors Are Clinically Heterogeneous and Epigenetically Distinct from PLAG1-Rearranged Adnexal and Salivary Gland Myoepithelial Tumors

PMID: 413428862026-02-04

Ibrutinib and PD-1 Blockade Potentiate Mesothelin-Targeting CAR T-cell Therapy in Preclinical Models of Pancreatic Cancer

PMID: 412311312026-02-04

Addition of Ipatasertib to Dual Anti-HER2 Maintenance Therapy in HER2-Positive Metastatic Breast Tumors with PIK3CA Mutations: The Phase Ib SOLTI-1507 IPATHER Trial

PMID: 413245682026-02-04

Cergutuzumab Amunaleukin in Combination with Atezolizumab in Patients with Carcinoembryonic Antigen-Positive Advanced/Metastatic Solid Tumors

PMID: 412525742026-02-04

大家都在搜

大家都在搜